How many institutions held INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value in Q3 2025?

98 institutional investors reported INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value for Q3 2025. Use the holders table for investor-level position and value details.

INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO)

Q: What does CUSIP 45773H409 represent in this 13F holders report?

CUSIP 45773H409 is the security identifier for INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 45773H409

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 66,777,963
Total 13F shares: 20,711,886
Share change: +10,542,179
Total reported value: $48,449,935
Put/Call ratio: 10%
Price per share: $2.34
Number of holders: 98
Value change: +$25,433,512
Number of buys: 45
Number of sells: 55

Quarterly Holders Quick Answers

What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2025
Previous quarter: Q2 2025

Recent filing periods for CUSIP 45773H409:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Adage Capital Management, L.P.	13D/G	—	10%	5,517,650	$12,911,301	$0	30 Sep 2025	13D/G
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13D/G	—	9.2%	3,633,333	$6,794,333	$0	31 Dec 2024	13D/G
VANGUARD GROUP INC	13F	Company	3%	2,009,145	$4,088,610	—	30 Jun 2025	13F
Deep Track Capital, LP	13F 13D/G	Company	2.4% from 13D/G	1,981,370	$4,032,088	—	30 Jun 2025	13F 13D/G
Stonepine Capital Management, LLC	13D/G	—	3.8%	1,434,997	$2,683,444	-$900,721	31 Mar 2025	13D/G
BANK OF AMERICA CORP /DE/	13F	Company	1.9%	1,270,607	$2,585,685	—	30 Jun 2025	13F
Jong Joseph Kim	3/4/5	Chief Executive Officer, Director	— mixed-class rows	3,113,086 mixed-class rows	$2,451,149	—	11 Mar 2022	3/4/5
BlackRock, Inc.	13D/G 13F	Company	1.5%	537,627	$1,099,608	-$3,642,379	30 Jun 2025	13D/G 13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.66%	437,549	$890,622	—	30 Jun 2025	13F
MORGAN STANLEY	13F	Company	0.6%	401,862	$817,792	—	30 Jun 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.52%	346,865	$705,870	—	30 Jun 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.49%	328,129	$667,743	—	30 Jun 2025	13F
NORTHERN TRUST CORP	13F	Company	0.38%	254,425	$517,755	—	30 Jun 2025	13F
UBS Group AG	13F	Company	0.3%	199,679	$406,348	—	30 Jun 2025	13F
Cubist Systematic Strategies, LLC	13F	Company	0.26%	171,561	$349,127	—	30 Jun 2025	13F
CITADEL ADVISORS LLC	13F	Company	0.25%	168,956	$343,825	—	30 Jun 2025	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.24%	163,260	$332,000	—	30 Jun 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.23%	151,267	$307,828	—	30 Jun 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.2%	136,774	$278,335	—	30 Jun 2025	13F
GMT CAPITAL CORP	13F	Company	0.19%	126,119	$256,652	—	30 Jun 2025	13F
STATE STREET CORP	13F	Company	0.19%	123,610	$251,546	—	30 Jun 2025	13F
ROYAL BANK OF CANADA	13F	Company	0.18%	122,213	$249,000	—	30 Jun 2025	13F
Qube Research & Technologies Ltd	13F	Company	0.17%	115,164	$234,359	—	30 Jun 2025	13F
FMR LLC	13F	Company	0.13%	87,344	$177,745	—	30 Jun 2025	13F
CIBC Private Wealth Group LLC	13F	Company	0.12%	80,000	$162,800	—	30 Jun 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.11%	72,727	$147,999	—	30 Jun 2025	13F
HRT FINANCIAL LP	13F	Company	0.11%	72,222	$146,000	—	30 Jun 2025	13F
BANK OF MONTREAL /CAN/	13F	Company	0.09%	57,946	$117,920	—	30 Jun 2025	13F
Concurrent Investment Advisors, LLC	13F	Company	0.08%	56,011	$113,982	—	30 Jun 2025	13F
Green Alpha Advisors, LLC	13F	Company	0.08%	53,308	$108,482	—	30 Jun 2025	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.08%	53,171	$108,204	—	30 Jun 2025	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.06%	42,917	$87,336	—	30 Jun 2025	13F
Y-Intercept (Hong Kong) Ltd	13F	Company	0.06%	42,171	$85,818	—	30 Jun 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.06%	40,456	$82,446	—	30 Jun 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.06%	39,683	$80,755	—	30 Jun 2025	13F
Virtu Financial LLC	13F	Company	0.06%	38,482	$78,000	—	30 Jun 2025	13F
Jain Global LLC	13F	Company	0.06%	37,601	$76,518	—	30 Jun 2025	13F
Squarepoint Ops LLC	13F	Company	0.05%	32,572	$66,284	—	30 Jun 2025	13F
HSBC HOLDINGS PLC	13F	Company	0.04%	26,075	$55,930	—	30 Jun 2025	13F
Simon X. Benito	3/4/5	Director	— mixed-class rows	17,275 mixed-class rows	$51,120	—	21 May 2025	3/4/5
Wendy L. Yarno	3/4/5	Director	— mixed-class rows	15,596 mixed-class rows	$47,980	—	21 May 2025	3/4/5
TWO SIGMA SECURITIES, LLC	13F	Company	0.03%	23,003	$46,811	—	30 Jun 2025	13F
Ann C. Miller	3/4/5	Director	— mixed-class rows	14,961 mixed-class rows	$46,792	—	21 May 2025	3/4/5
Jay Shepard	3/4/5	Director	— mixed-class rows	14,293 mixed-class rows	$45,543	—	21 May 2025	3/4/5
Roger D. Dansey	3/4/5	Director	— mixed-class rows	14,000 mixed-class rows	$44,995	—	21 May 2025	3/4/5
XTX Topco Ltd	13F	Company	0.03%	22,038	$44,847	—	30 Jun 2025	13F
Lota S. Zoth	3/4/5	Director	— mixed-class rows	13,810 mixed-class rows	$44,640	—	21 May 2025	3/4/5
NOMURA HOLDINGS INC	13F	Company	0.03%	20,987	$42,709	—	30 Jun 2025	13F
Prime Capital Investment Advisors, LLC	13F	Company	0.03%	20,372	$41,457	—	30 Jun 2025	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.03%	18,000	$36,630	—	30 Jun 2025	13F

Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) as of Q3 2025

As of 30 Sep 2025, INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,711,886 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, Boxer Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, D. E. Shaw & Co., Inc., MORGAN STANLEY, BANK OF AMERICA CORP /DE/, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 98 institutional shareholders reporting positions in this security for the Q3 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

101

Q3 2025 holders

Holder diff

-3

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 Value $	Q3 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.